Drugs Information Online
Drugs and diseases reference index

Drugs and diseases reference index
Search
EN

Drugs reference index «Medroxyprogesterone Injectable Suspension (subcutaneous)»

Medroxyprogesterone Injectable Suspension (subcutaneous)

Generic Name: Medroxyprogesterone (meh-DROX-ee-pro-JESS-tuh-rone)Brand Name: depo-subQ provera 104

Medroxyprogesterone Injectable Suspension (subcutaneous) may decrease the amount of calcium in your bones. The longer you use Medroxyprogesterone Injectable Suspension (subcutaneous), the more calcium you are likely to lose. The calcium may not return completely once you stop using Medroxyprogesterone Injectable Suspension (subcutaneous). Loss of bone calcium may cause weak bones (osteoporosis). This could increase the risk of bone fracture, especially after menopause. It is not known if using Medroxyprogesterone Injectable Suspension (subcutaneous) during adolescence or early adulthood will increase your chances of developing osteoporosis later in life. Medroxyprogesterone Injectable Suspension (subcutaneous) should be used as a long-term birth control method (more than 2 years) only if other birth control methods are not right for you.

Medroxyprogesterone Injectable Suspension (subcutaneous) is used for:

Preventing pregnancy. It is also used to manage pain caused by endometriosis. It may also be used for certain conditions as determined by your doctor.

Medroxyprogesterone Injectable Suspension (subcutaneous) is a progestin hormone. It works by inhibiting chemicals released from the brain, which normally stimulate the ovaries to produce eggs. It also alters the lining of the uterus so it is less likely to accept a fertilized egg. These effects work together to reduce the chance of pregnancy occurring after intercourse.

Do NOT use Medroxyprogesterone Injectable Suspension (subcutaneous) if:

  • you are allergic to any ingredient in Medroxyprogesterone Injectable Suspension (subcutaneous)
  • you have a history of bleeding in the brain or stroke, breast cancer, undiagnosed vaginal bleeding, or blood clots
  • you are pregnant

Contact your doctor or health care provider right away if any of these apply to you.

Before using Medroxyprogesterone Injectable Suspension (subcutaneous):

Some medical conditions may interact with Medroxyprogesterone Injectable Suspension (subcutaneous). Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

  • if you are pregnant, planning to become pregnant, or are breast-feeding
  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if you have allergies to medicines, foods, or other substances
  • if you have diabetes or depression

Some MEDICINES MAY INTERACT with Medroxyprogesterone Injectable Suspension (subcutaneous). Tell your health care provider if you are taking any of the following medicines.

  • Aminoglutethimide or rifampin because they may decrease Medroxyprogesterone Injectable Suspension (subcutaneous)'s effectiveness and side effects, such as menstrual irregularities (spotting, breakthrough bleeding) and/or pregnancy, may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Medroxyprogesterone Injectable Suspension (subcutaneous) may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Medroxyprogesterone Injectable Suspension (subcutaneous):

Use Medroxyprogesterone Injectable Suspension (subcutaneous) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

  • An extra patient leaflet is available with Medroxyprogesterone Injectable Suspension (subcutaneous). Talk to your pharmacist if you have questions about this information.
  • Medroxyprogesterone Injectable Suspension (subcutaneous) is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Medroxyprogesterone Injectable Suspension (subcutaneous) at home, a health care provider will teach you how to use it. Be sure you understand how to use Medroxyprogesterone Injectable Suspension (subcutaneous). Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.
  • Do not use Medroxyprogesterone Injectable Suspension (subcutaneous) if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.
  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.
  • Medroxyprogesterone Injectable Suspension (subcutaneous) is given every 3 months. It is very important that you return to your doctor's office for your next injection promptly at the end of the 3-month interval.
  • If you miss a dose of Medroxyprogesterone Injectable Suspension (subcutaneous), contact your doctor right away.

Ask your health care provider any questions you may have about how to use Medroxyprogesterone Injectable Suspension (subcutaneous).

Important safety information:

  • Medroxyprogesterone Injectable Suspension (subcutaneous) may cause drowsiness or dizziness. These effects may be worse if you use it with alcohol or certain medicines. Use Medroxyprogesterone Injectable Suspension (subcutaneous) with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
  • Medroxyprogesterone Injectable Suspension (subcutaneous) may cause dark skin patches on your face. Exposure to the sun may make these patches darker. If patches develop, use a sunscreen or protective clothing when exposed to the sun, sunlamps, or tanning booths.
  • Medroxyprogesterone Injectable Suspension (subcutaneous) may cause a decrease in the amount of calcium in your bones. A decrease in bone calcium is of most concern if you have the following risk factors: adolescence, bone disease, anorexia nervosa (an eating disorder), a strong family history of osteoporosis, if you take certain medicines (eg, for epilepsy or steroids), or if you drink a lot of alcohol or smoke cigarettes often. If you need a birth control method for more than 2 years, your health care provider may switch you to another method or test you for weak bones. When Medroxyprogesterone Injectable Suspension (subcutaneous) is stopped, the calcium in bones begins to come back. Your health care provider may recommend that you take calcium or vitamin D to help lower the amount of calcium lost from your bones.
  • Diabetes patients - Medroxyprogesterone Injectable Suspension (subcutaneous) may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.
  • Medroxyprogesterone Injectable Suspension (subcutaneous) should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: Do not use Medroxyprogesterone Injectable Suspension (subcutaneous) if you are pregnant. If you think you may be pregnant, contact your doctor right away. Medroxyprogesterone Injectable Suspension (subcutaneous) is found in breast milk. If you are or will be breast-feeding while you use Medroxyprogesterone Injectable Suspension (subcutaneous), check with your doctor. Discuss any possible risks to your baby.
Possible side effects of Medroxyprogesterone Injectable Suspension (subcutaneous):

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Acne; changes in menstrual flow, including breakthrough bleeding, spotting, or missed periods; dizziness; drowsiness; fever; headache; hot flashes; nausea; nervousness; pain; rash; sleeplessness; stomach pain; weakness; weight gain or loss.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blood clots; chest pain; depression; partial or complete loss of vision or changes in vision; shortness of breath; slurred speech; sudden loss of coordination; sudden or severe headache; swelling of fingers or ankles; weakness, numbness, or pain in the arms or legs; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org), or emergency room immediately.

Proper storage of Medroxyprogesterone Injectable Suspension (subcutaneous):

Store Medroxyprogesterone Injectable Suspension (subcutaneous) at room temperature between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Medroxyprogesterone Injectable Suspension (subcutaneous) out of the reach of children and away from pets.

General information:

  • If you have any questions about Medroxyprogesterone Injectable Suspension (subcutaneous), please talk with your doctor, pharmacist, or other health care provider.
  • Medroxyprogesterone Injectable Suspension (subcutaneous) is to be used only by the patient for whom it is prescribed. Do not share it with other people.
  • If your symptoms do not improve or if they become worse, check with your doctor.

This information is a summary only. It does not contain all information about Medroxyprogesterone Injectable Suspension (subcutaneous). If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Comment «Medroxyprogesterone Injectable Suspension (subcutaneous)»